Clinicopathological features and prognostic nomogram of giant cell carcinoma of the lung: A population-based study

被引:0
作者
He, Jiang [1 ]
Ni, Jin-Ping [2 ]
Li, Guang-Bin [1 ]
Yao, Jie [1 ]
Ni, Bin [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 1, Dept Thorac Surg, 899 Pinghai Rd, Suzhou 215006, Peoples R China
[2] Shanghai Jiao Tong Univ, Suzhou Kowloon Hosp, Sch Med, Suzhou, Peoples R China
关键词
giant cell carcinoma of the lung; nomogram; propensity score matching analysis; SEER database; PULMONARY SARCOMATOID CARCINOMA; MOLECULAR-FEATURES; REVEALS;
D O I
10.1111/crj.13586
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
BackgroundDue to its rarity, the features and prognosis of giant cell carcinoma of the lung (GCCL) are not well defined. The present study aimed to describe the clinicopathological features and prognostic analysis of this rare disease, compare it with lung adenocarcinoma (LAC), further determine the prognostic factors and establish a nomogram. MethodsPatients diagnosed with GCCL and LAC were identified from the SEER database between 2004 and 2016. The features and survival between GCCL and LAC were compared in the unmatched and matched cohorts after propensity score matching (PSM) analysis. Univariate and multivariate Cox analyses were used to identify the prognostic factors, and a nomogram was constructed. Area under the curve (AUC), C-index, calibration curve and decision curve analysis (DCA) were used to confirm the established nomogram. ResultsA total of 295 patient diagnosed with GCCL and 149 082 patients with LAC were identified. Compared with LAC, patients with GCCL tend to be younger, male, black and have pathological Grade III/IV GCCL, more proportion of AJCC-TNM-IV, T3/T4 and distant metastases. The 1-, 2- and 5-year OS rates of the patients with GCCL were 21.7%, 13.4% and 7.9%, respectively. The median OS and CSS were 3 and 4 months, respectively. Patients with GCCL had significantly shorter OS and CSS than those with LAC in the unmatched and matched cohorts after PSM. Multivariate Cox analysis demonstrated that T, N and M stages and use of chemotherapy and surgery were independent of survival. Furthermore, we constructed a prognostic nomogram for OS and CSS by using independent prognostic factors. The C-index of OS-specific nomogram is 0.78 (0.74-0.81), and the C-index of CSS-specific nomogram is 0.77 (0.73-0.80). The calibration curve and ROC analysis showed good predictive capability of these nomograms. DCA showed that the nomogram had greater clinical practical value in predicting the OS and CSS of GCCL than TNM staging. ConclusionGCCL have distinct clinicopathological characteristics and significantly worse clinical outcomes. Prognostic nomograms for overall survival (OS) and CSS were constructed.
引用
收藏
页码:197 / 210
页数:14
相关论文
共 50 条
  • [41] Development and Validation of Prognostic Nomogram for Primary Peritoneal Serous Carcinoma Compared With FIGO Staging System: A Population-Based Study
    Chen, Ming
    Wen, Zhenzhen
    Qi, Zhengwei
    Gao, Min
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [42] A prognostic nomogram in patients with distant metastasis of pancreatic neuroendocrine tumors: a population-based study
    Cai, Jin-Song
    Chen, Hai-Yan
    Lu, Yuan-Fei
    Yu, Ri-Sheng
    FUTURE ONCOLOGY, 2020, 16 (02) : 4369 - 4379
  • [43] Development and validation of a prognostic nomogram for Hurthle cell thyroid carcinoma: a SEER-based study
    Shen, Cong
    Zhao, Yunzhe
    Qiu, Xiangyuan
    Li, Peng
    Ding, Ying
    Wang, Wenlong
    Sun, Botao
    Li, Xinying
    Jiang, Wei
    GLAND SURGERY, 2022, 11 (03) : 535 - 544
  • [44] Development and validation of a nomogram for primary duodenal carcinoma: a multicenter, population-based study
    Yang, Qin-Yu
    Tang, Chao-Tao
    Huang, Yun-Feng
    Shao, Dan-Ting
    Shu, Xu
    FUTURE ONCOLOGY, 2022, 18 (10) : 1245 - 1258
  • [45] Construction and validation of a prognostic nomogram for locally recurrent rectal cancer: a population-based study
    Huang, Xiao
    Zhou, Minwei
    Li, Zhenyang
    Zhao, Ziheng
    Zhou, Yiming
    Zang, Yiwen
    Yang, Yi
    Wang, Zihao
    Chen, Zongyou
    Gu, Xiaodong
    Zhang, Jian
    Xiang, Jianbin
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (03) : 1293 - +
  • [46] Clinical features and prognostic factors of patients with inoperable hepatocellular carcinoma treated with chemotherapy: a population-based study
    Gao, Yang
    Xu, Yihang
    Wang, Yong
    Lu, Jian
    Guo, Jin-He
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (03) : 1122 - 1140
  • [47] Construction and validation of a prognostic nomogram for primary vulvar melanoma: a SEER population-based study
    Zhou, Hongyu
    Zou, Xuan
    Li, Haoran
    Chen, Lihua
    Cheng, Xi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (12) : 1386 - 1394
  • [48] Development of a Survival Nomogram for Esophageal Squamous Cell Carcinoma Patients: a Population-Based Analysis
    Guangrong Lu
    Weiyue Fang
    Ying Lin
    He Huang
    Journal of Gastrointestinal Cancer, 2024, 55 : 391 - 401
  • [49] Clinical features and prognostic nomogram development for cancer-specific death in patients with dual primary lung cancer: a population-based study from SEER database
    Tenghao Rong
    Cheng Ai
    Tong Yang
    Qingchen Wu
    Min Zhang
    Journal of Cardiothoracic Surgery, 20 (1)
  • [50] Development of a Survival Nomogram for Esophageal Squamous Cell Carcinoma Patients: a Population-Based Analysis
    Lu, Guangrong
    Fang, Weiyue
    Lin, Ying
    Huang, He
    JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (01) : 391 - 401